Stockreport

Synthorx to Present at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Synthorx, Inc. - Common Stock  (THOR) 
Last synthorx, inc. - common stock earnings: 11/5 04:05 pm Check Earnings Report
PDF SAN DIEGO, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and aut [Read more]